This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakashiro, K.-i. Articles by Sato, M. Search for Related Content PubMed PubMed Citation Articles by Nakashiro, K.-i. Articles by Sato, M.

Down-regulation of TSC-22 (Transforming Growth Factor ß-stimulated Clone 22) Markedly Enhances the Growth of a Human Salivary Gland Cancer Cell Line in Vitro and in Vivo¹

Second Department of Oral and Maxillofacial Surgery [K-i. N., H. K., S. H., D. U., F. O., H. Y., M. S.], Department of Biochemistry [Y. M.], and Department of Pathology [H. H.], Tokushima University School of Dentistry, Tokushima 770, Japan

We have recently isolated TSC-22 (transforming growth factor ß-stimulated clone 22) cDNA as a new anticancer drug (Vesnarinone)-inducible gene in a human salivary gland cancer cell line, TYS. We conducted the present study to examine whether up-regulation or down-regulation of TSC-22 can affect the growth of TYS cells in vitro and in vivo. We constructed an expression vector containing sense- or antisense-oriented human TSC-22 cDNA under the transcriptional control of the SR promoter. We cotransfected TYS cells with the sense or antisense expression vector and pSV2neo and obtained more than 200 G418-resistant colonies in each sense or antisense transfectant. Approximately 80% of representative G418-resistant clones expressed the transcripts from transfected sense or antisense TSC-22 cDNA. To avoid the clonal heterogeneity of the cells, we mixed all of the G418-resistant colonies together in each sense or antisense transfectant and examined the expression of TSC-22 protein, in vitro growth, and the tumorigenicity in nude mice. The expression of TSC-22 protein was examined by solid-phase ELISA using a specific antibody against recombinant TSC-22 protein. The expression of TSC-22 protein was up-regulated in the sense transfectants and down-regulated in the antisense transfectants. Contrary to our expectation, up-regulation of TSC-22 protein did not affect both in vitro and in vivo growth of TYS cells. However, down-regulation of TSC-22 markedly enhanced the growth of TYS cells in vitro and in vivo. Furthermore, we examined the expression of TSC-22 mRNA in several human salivary gland tumors. The mRNA expression of TSC-22 in benign and malignant salivary gland tumors was significantly decreased when compared to that in tumor-free salivary glands (P < 0.05; one-way ANOVA), and in some salivary gland tumors, the expression of TSC-22 mRNA was not detectable by reverse transcription-PCR. These results suggest that down-regulation of TSC-22 may play a major role on salivary gland tumorigenesis.

¹ This study was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, and by a Tokushima University Institutional grant.

² To whom requests for reprints should be addressed, at Second Department of Oral and Maxillofacial Surgery, Tokushima University School of Dentistry, 3-18-15 Kuramoto, Tokushima 770, Japan. Phone: 81-886-33-7354; Fax: 81-886-33-7462; E-mail: kawamata@dent.tokushima-u.ac.jp.

Received 7/17/97. Accepted 12/ 1/97.

This article has been cited by other articles:

				X. Wu, M. Yamada-Mabuchi, E. J. Morris, P. S. Tanwar, L. Dobens, S. Gluderer, S. Khan, J. Cao, H. Stocker, E. Hafen, et al. The Drosophila homolog of human tumor suppressor TSC-22 promotes cellular growth, proliferation, and survival PNAS, April 8, 2008; 105(14): 5414 - 5419. [Abstract] [Full Text] [PDF]

				R. Soundararajan, J. Wang, D. Melters, and D. Pearce Differential Activities of Glucocorticoid-induced Leucine Zipper Protein Isoforms J. Biol. Chem., December 14, 2007; 282(50): 36303 - 36313. [Abstract] [Full Text] [PDF]

				M. Iida, C. H. Anna, N. D. Gaskin, N. J. Walker, and T. R. Devereux The Putative Tumor Suppressor Tsc-22 is Downregulated Early in Chemically Induced Hepatocarcinogenesis and may be a Suppressor of Gadd45b Toxicol. Sci., September 1, 2007; 99(1): 43 - 50. [Abstract] [Full Text] [PDF]

				M. Iida, C. H. Anna, W. M. Holliday, J. B. Collins, M. L. Cunningham, R. C. Sills, and T. R. Devereux Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens Carcinogenesis, March 1, 2005; 26(3): 689 - 699. [Abstract] [Full Text] [PDF]

				M. Okamoto, S. Furuichi, Y. Nishioka, T. Oshikawa, T. Tano, S. U. Ahmed, K. Takeda, S. Akira, Y. Ryoma, Y. Moriya, et al. Expression of Toll-Like Receptor 4 on Dendritic Cells Is Significant for Anticancer Effect of Dendritic Cell-Based Immunotherapy in Combination with an Active Component of OK-432, a Streptococcal Preparation Cancer Res., August 1, 2004; 64(15): 5461 - 5470. [Abstract] [Full Text] [PDF]

				K.-i. Nakashiro, S. Hara, Y. Shinohara, M. Oyasu, H. Kawamata, S. Shintani, H. Hamakawa, and R. Oyasu Phenotypic Switch from Paracrine to Autocrine Role of Hepatocyte Growth Factor in an Androgen-Independent Human Prostatic Carcinoma Cell Line, CWR22R Am. J. Pathol., August 1, 2004; 165(2): 533 - 540. [Abstract] [Full Text] [PDF]

				C. M. Cham, H. Xu, J. P. O'Keefe, F. V. Rivas, P. Zagouras, and T. F. Gajewski Gene Array and Protein Expression Profiles Suggest Post-transcriptional Regulation during CD8+ T Cell Differentiation J. Biol. Chem., May 2, 2003; 278(19): 17044 - 17052. [Abstract] [Full Text] [PDF]

				R. A. Gupta, P. Sarraf, J. A. Brockman, S. B. Shappell, L. A. Raftery, T. M. Willson, and R. N. DuBois Peroxisome Proliferator-activated Receptor gamma and Transforming Growth Factor-beta Pathways Inhibit Intestinal Epithelial Cell Growth by Regulating Levels of TSC-22 J. Biol. Chem., February 21, 2003; 278(9): 7431 - 7438. [Abstract] [Full Text] [PDF]

				M. Okamoto, T. Oshikawa, T. Tano, G. Ohe, S. Furuichi, H. Nishikawa, S. U. Ahmed, S. Akashi, K. Miyake, O. Takeuchi, et al. Involvement of Toll-Like Receptor 4 Signaling in Interferon-{gamma} Production and Antitumor Effect by Streptococcal Agent OK-432 J Natl Cancer Inst, February 19, 2003; 95(4): 316 - 326. [Abstract] [Full Text] [PDF]

				K.-i. Nakashiro, Y. Hayashi, A. Kita, T. Tamatani, A. Chlenski, N. Usuda, K. Hattori, J. K. Reddy, and R. Oyasu Role of Peroxisome Proliferator-Activated Receptor {gamma} and Its Ligands in Non-Neoplastic and Neoplastic Human Urothelial Cells Am. J. Pathol., August 1, 2001; 159(2): 591 - 597. [Abstract] [Full Text]

				L. C. Amler, D. B. Agus, C. LeDuc, M. L. Sapinoso, W. D. Fox, S. Kern, D. Lee, V. Wang, M. Leysens, B. Higgins, et al. Dysregulated Expression of Androgen-responsive and Nonresponsive Genes in the Androgen-independent Prostate Cancer Xenograft Model CWR22-R Cancer Res., November 1, 2000; 60(21): 6134 - 6141. [Abstract] [Full Text]

				K.-i. Nakashiro, M. Okamoto, Y. Hayashi, and R. Oyasu Hepatocyte Growth Factor Secreted by Prostate-Derived Stromal Cells Stimulates Growth of Androgen-Independent Human Prostatic Carcinoma Cells Am. J. Pathol., September 1, 2000; 157(3): 795 - 803. [Abstract] [Full Text] [PDF]

				H. A. Kester, C. Blanchetot, J. den Hertog, P. T. van der Saag, and B. van der Burg Transforming Growth Factor-beta -stimulated Clone-22 Is a Member of a Family of Leucine Zipper Proteins That Can Homo- and Heterodimerize and Has Transcriptional Repressor Activity J. Biol. Chem., September 24, 1999; 274(39): 27439 - 27447. [Abstract] [Full Text] [PDF]